Tenofovir DF + Efavirenz (TDF+EFV) Versus Tenofovir DF + Efavirenz + Lamivudine (TDF+EFV+3TC) Maintenance Regimen in Virologically Controlled Patients: COOL Trial

PHASE4CompletedINTERVENTIONAL

Enrollment

140

Participants

Timeline

Start Date

March 31, 2003

Primary Completion Date

June 30, 2005

Study Completion Date

September 30, 2005

Conditions

HIV Infections

Interventions

DRUG

EFV+TDF

DRUG

EFV+3TC+TDF

Trial Locations (1)

France and French West Indies, Paris